QCM Quantification of Endocrine Disruptor Activity

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R41ES013004-01A1
Agency Tracking Number: ES013004
Amount: $85,395.00
Phase: Phase I
Program: STTR
Awards Year: 2004
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
OXFORD BIOMEDICAL RESEARCH, INC.
2165 AVON INDUSTRIAL DRIVE, ROCHESTER HILLS, MI, 48309
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 XIANGQUN ZENG
 (248) 370-2881
 ZENG@OAKLAND.EDU
Business Contact
 DENIS CALLEWAEERT
Phone: (248) 852-8815
Email: CALLEWAE@OXFORDBIOMED.COM
Research Institution
 OAKLAND UNIVERSITY
 544 O'DOWD HALL
OXFORD, MI, 48309
 Nonprofit college or university
Abstract
DESCRIPTION (provided by applicant): Environmental agents with estrogen-like activity are a major public health issue. Although a variety of assays have been developed to detect binding to the estrogen receptor (ER) and other assays have been developed to monitor subsequent effects on estrogen sensitive gene transcription, an Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) recently reported difficulties with all available methods. We are developing quartz crystal microbalance (QCM) platform technology for the quantitative high-throughput analysis of complex macromolecular interactions. The focus of this project is the development of QCM biosensors for rapid quantification of the influence of endocrine disrupters on the interactions among the estrogen receptor (ER), coactivators or corepressors and the estrogen response element (ERE). QCM has been applied to study interactions of proteins with small molecules, protein-protein interactions, and DMA hybridization. It is expected that QCM will provide heretofore inaccessible quantitative information regarding effects of endocrine disrupters on the kinetics and affinity of the ER for the ERE as well as comparable information about the influence of endocrine disrupters on interactions between the ER and coactivators, corepressors, and other transcription factors whose interactions regulate estrogen-responsive genes in many cell types and organisms. Major advantages of QCM include high sensitivity, low cost, real time label-free, quantitative analysis. Given the U.S. congressional mandate and World Health Organization recommendations for endocrine disrupter testing of chemicals, we anticipate strong market demand for ERE biosensor technology.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government